Types of Sickle Cell Disease | Cadabam's CDC

Types Of Sickle Cell Disease

Sickle cell disease (SCD) is a group of inherited red blood cell disorders characterized by abnormal hemoglobin that causes red blood cells to become rigid, sticky, and crescent- or "sickle"-shaped. The main types of sickle cell disease include HbSS (Sickle Cell Anemia), HbSC, HbS Beta-Zero Thalassemia, and HbS Beta-Plus Thalassemia, alongside rarer genetic variants such as HbSD, HbSE, and HbSO. Identifying the specific type early in childhood is crucial because each variant presents varying degrees of physical severity, risk of complications, and potential long-term impacts on a child's neurodevelopment and learning abilities.

---

What is types of sickle cell disease?

Sickle cell disease is caused by genetic mutations in the beta-globin gene, inherited in an autosomal recessive pattern. A child must inherit two abnormal hemoglobin genes—at least one of which is the sickle hemoglobin gene ("S")—to manifest sickle cell disease. When red blood cells adopt a sickle shape, they break down prematurely (causing chronic anemia) and can become trapped in small blood vessels, blocking blood flow and oxygen delivery throughout the body.

The primary types of sickle cell disease vary based on the specific combination of abnormal genes inherited from the parents:

• HbSS (Sickle Cell Anemia): This is the most common and severe form of the disease. It occurs when a child inherits two "S" hemoglobin genes (one from each parent). Children with HbSS experience severe chronic anemia, frequent painful vaso-occlusive crises, high susceptibility to infections, and an elevated risk of micro-strokes or silent cerebral infarcts that can disrupt cognitive development.
• HbS Beta-Zero Thalassemia ($\text\beta^0$): This severe type occurs when a child inherits one sickle cell gene ("S") and one beta-zero thalassemia gene. Because the body produces no normal beta-globin, the clinical presentation and neurodevelopmental risks are almost identical to HbSS.
• HbSC Disease: This type occurs when a child inherits one "S" gene and one "C" gene (another abnormal hemoglobin). It is generally a moderate form of the disease. While children with HbSC typically experience milder anemia, they remain vulnerable to complications like pain crises, eye problems (retinopathy), and joint issues.
• HbS Beta-Plus Thalassemia ($\text\beta^+$): This form occurs when a child inherits an "S" gene along with a beta-plus thalassemia gene. Because the body continues to produce reduced amounts of normal beta-globin, symptoms are often milder, though routine monitoring remains essential.
• Rare Types (HbSD, HbSE, and HbSO): These variants occur when the sickle gene combines with other uncommon abnormal hemoglobin types (D, E, or O). Their clinical severity varies widely from mild anemia to moderate pain and developmental impacts.
• Sickle Cell Trait (HbAS): Inheriting one sickle gene ("S") and one normal gene ("A") results in sickle cell trait. Trait is not a disease, and individuals rarely experience symptoms or developmental delays, but they can pass the gene to their children.

Summary Comparison of Sickle Cell Disease Types

Type of Sickle Cell Disease	Gene Combination	Severity Level	Key Physical & Developmental Risks
HbSS (Sickle Cell Anemia)	S + S	Severe	Severe anemia, frequent pain crises, stroke risk, cognitive impacts
HbS Beta-Zero Thalassemia	S + $\beta^0$	Severe	Similar to HbSS; severe anemia, high infection risk, developmental delay risks
HbSC Disease	S + C	Moderate	Moderate anemia, pain crises, retinopathy, joint complications
HbS Beta-Plus Thalassemia	S + $\beta^+$	Mild to Moderate	Mild anemia, fewer pain crises, generally lower risk of cognitive disruption
Rare Types (HbSD, HbSE, HbSO)	S + D, E, or O	Variable	Varies from mild to moderate anemia, pain, and developmental monitoring needs
Sickle Cell Trait (HbAS)	S + A	Asymptomatic / Trait	Generally no clinical symptoms; carrier status for future generations

---

Supporting Your Child's Development

Early detection and comprehensive medical and developmental support can significantly improve outcomes for children living with sickle cell disease. Routine pediatric assessments help track neurodevelopmental milestones, manage executive function challenges, and provide tailored academic and therapeutic interventions.

If you have concerns about your child's growth, developmental milestones, or learning needs, expert guidance is available. Contact Cadabam's Child Development Center to connect with our pediatric specialists and schedule a comprehensive assessment.

---

Disclaimer: This content is for general information only and is not a substitute for professional medical advice. Always consult a qualified professional for a formal assessment.